Real-time enrollment status for this iga nephropathy clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT06564142 |
| Recruiting Status | Active, Not Recruiting |
| Condition | IgA Nephropathy |
| Phase | Clinical Trial |
| Target Enrollment | 480 participants |
| Active Locations | 72 sites in the US |
| Sponsor | Alpine Immune Sciences Inc, A Subsidiary of Vertex |
| Last Updated on CT.gov | December 17, 2025 (Dec 17, 2025) |
As of March 2, 2026: Clinical trial NCT06564142 is currently active_not_recruiting participants. This clinical trial study for iga nephropathy is not currently accepting new participants at 72 locations across the United States. The study is sponsored by Alpine Immune Sciences Inc, A Subsidiary of Vertex. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06564142 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 72 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06564142 was last updated Dec 17, 2025 (December 17, 2025). HelloStudys verifies this status automatically.